Abiopharma

🔍 COOK TIMOTHY D (Executive)

Company: Apple Inc. (AAPL)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 131,576 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,411,994.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 66,627 shares of Common Stock at $255.63 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,345,367.00 | transaction_form_type: 4 | Footnotes: F4, F3
• Sold 5,087 shares of Common Stock at $251.25 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,340,280.00 | transaction_form_type: 4 | Footnotes: F5, F6, F3
• Sold 9,147 shares of Common Stock at $252.11 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,331,133.00 | transaction_form_type: 4 | Footnotes: F5, F7, F3
• Sold 1,878 shares of Common Stock at $253.13 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,329,255.00 | transaction_form_type: 4 | Footnotes: F5, F8, F3
• Sold 16,083 shares of Common Stock at $254.37 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,313,172.00 | transaction_form_type: 4 | Footnotes: F5, F9, F3
• Sold 28,188 shares of Common Stock at $255.17 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,284,984.00 | transaction_form_type: 4 | Footnotes: F5, F10, F3
• Sold 4,566 shares of Common Stock at $256.0 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,280,418.00 | transaction_form_type: 4 | Footnotes: F5, F11, F3
• Sold 85,080 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F12, F12
• Sold 22,159 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,159.00 | transaction_form_type: 4 | Footnotes: F1, F1, F13, F13
• Sold 24,337 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 48,673.00 | transaction_form_type: 4 | Footnotes: F1, F1, F14, F14

Footnotes:

• F1: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
• F2: The number of securities reported reflects the acquisition on January 30, 2026 of 123 shares of Apple Inc.'s common stock pursuant to the Apple Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 1, 2025 through January 30, 2026.
• F3: These shares are held through Mr. Cook's trust.
• F4: Shares withheld by Apple to satisfy tax withholding requirements on vesting of RSUs.
• F5: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024.
• F6: This transaction was executed in multiple trades at prices ranging from $250.73 to $251.69; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Apple, or a security holder of Apple.
• F7: This transaction was executed in multiple trades at prices ranging from $251.73 to $252.68; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Apple, or a security holder of Apple.
• F8: This transaction was executed in multiple trades at prices ranging from $252.75 to $253.61; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Apple, or a security holder of Apple.
• F9: This transaction was executed in multiple trades at prices ranging from $253.76 to $254.75; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Apple, or a security holder of Apple.
• F10: This transaction was executed in multiple trades at prices ranging from $254.76 to $255.75; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Apple, or a security holder of Apple.
• F11: This transaction was executed in multiple trades at prices ranging from $255.82 to $256.10; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Apple, or a security holder of Apple.
• F12: This award was granted on September 26, 2021. 85,081 RSUs subject to the award settled on April 1, 2024, and 85,080 RSUs settled on each of April 1, 2025 and April 1, 2026.
• F13: This award was granted on September 25, 2022. 22,159 RSUs subject to the award settled on each of April 1, 2025 and April 1, 2026, and 22,159 RSUs are scheduled to settle on April 1, 2027, subject to the terms and conditions of the underlying award agreement.
• F14: This award was granted on October 1, 2023. 24,337 RSUs subject to the award settled on April 1, 2026. 24,337 RSUs are scheduled to settle on April 1, 2027 and 24,336 RSUs are scheduled to settle on April 1, 2028, subject to the terms and conditions of the underlying award agreement.